c-Met(肝细胞生长因子受体,HGFR)是一种具有酪氨酸激酶活性的蛋白质。主要的单链前体蛋白在翻译后被切割以产生 α 和 β 亚基,它们通过二硫键连接形成成熟受体。c-Met 是一种膜受体,对胚胎发育和伤口愈合至关重要。肝细胞生长因子 (HGF) 是 c-Met 受体的唯一已知配体。c-Met 通常由上皮细胞表达,而 HGF 的表达仅限于间充质细胞。在 HGF 刺激下,c-Met 会诱导多种生物反应,这些反应共同导致一种称为侵袭性生长的程序。
c-Met (hepatocyte growth factor receptor, HGFR) is a protein possesses tyrosine kinase activity. The primary single chain precursor protein is post-translationally cleaved to produce the alpha and beta subunits, which are disulfide linked to form the mature receptor. c-Met is a membrane receptor that is essential for embryonic development and wound healing. Hepatocyte growth factor (HGF) is the only known ligand of the c-Met receptor. c-Met is normally expressed by cells of epithelial origin, while expression of HGF is restricted to cells of mesenchymalorigin. Upon HGF stimulation, c-Met induces several biological responses that collectively give rise to a program known as invasive growth.
3-Fluoro-desmethyl-cabozantinib-C3-O-C3-PEG-acid 是一种靶蛋白配体-连接子偶联物 (target protein ligand-linker conjugate),结合了 c-Met 配体 和 PROTAC 连接子 (MS-U02421),可募集 E3 连接酶,并可用于合成诸如 SJF-8240 (MS-R96152) 等 PROTAC。
DOTA-SMIC-1014 是 c-Met 靶向肽 SMIC-1014 (MS-U30629) 的 DOTA 螯合剂偶联前体,可结合 c-Met 胞外域 (Kd = 42.83 nM),经放射性标记为 [68Ga]Ga-SMIC-1014 后可作为正电子发射断层扫描 (PET) 探针,在异种移植物中实现特异性肿瘤摄取,并作为靶向 c-Met 的诊断探针发挥作用,而 SMIC-1014 可用于结肠癌、肝细胞癌、前列腺癌的相关研究。
© 2026 MolStrong. 保留所有权利。粤ICP备2023004355号
可通过CAS号进行批量搜索,一行一个CAS号